GB9724143D0 - Pharmaceutical conjugate - Google Patents

Pharmaceutical conjugate

Info

Publication number
GB9724143D0
GB9724143D0 GBGB9724143.4A GB9724143A GB9724143D0 GB 9724143 D0 GB9724143 D0 GB 9724143D0 GB 9724143 A GB9724143 A GB 9724143A GB 9724143 D0 GB9724143 D0 GB 9724143D0
Authority
GB
United Kingdom
Prior art keywords
carrier
pharmaceutical conjugate
linker
functional group
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9724143.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Priority to GBGB9724143.4A priority Critical patent/GB9724143D0/en
Publication of GB9724143D0 publication Critical patent/GB9724143D0/en
Priority to DE69829880T priority patent/DE69829880T2/de
Priority to AT98954603T priority patent/ATE293459T1/de
Priority to DK98954603T priority patent/DK1047452T3/da
Priority to JP2000520816A priority patent/JP2001523648A/ja
Priority to ES98954603T priority patent/ES2238774T3/es
Priority to PCT/GB1998/003442 priority patent/WO1999025383A1/en
Priority to AU11658/99A priority patent/AU1165899A/en
Priority to EP98954603A priority patent/EP1047452B1/en
Priority to US10/302,428 priority patent/US7001989B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9724143.4A 1997-11-14 1997-11-14 Pharmaceutical conjugate Ceased GB9724143D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9724143.4A GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate
EP98954603A EP1047452B1 (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents
JP2000520816A JP2001523648A (ja) 1997-11-14 1998-11-16 ２種の活性剤を含むコンジュゲート
AT98954603T ATE293459T1 (de) 1997-11-14 1998-11-16 Konjugate enthaltend zwei wirkstoffe
DK98954603T DK1047452T3 (da) 1997-11-14 1998-11-16 Konjugater omfattende to aktive midler
DE69829880T DE69829880T2 (de) 1997-11-14 1998-11-16 Konjugate enthaltend zwei wirkstoffe
ES98954603T ES2238774T3 (es) 1997-11-14 1998-11-16 Conjugados que comprenden dos agentes activos.
PCT/GB1998/003442 WO1999025383A1 (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents
AU11658/99A AU1165899A (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents
US10/302,428 US7001989B2 (en) 1997-11-14 2002-11-22 Conjugates comprising two active agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724143.4A GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate

Publications (1)

Publication Number Publication Date
GB9724143D0 true GB9724143D0 (en) 1998-01-14

Family

ID=10822123

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9724143.4A Ceased GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate

Country Status (9)

Country Link
US (1) US7001989B2 (https=)
EP (1) EP1047452B1 (https=)
JP (1) JP2001523648A (https=)
AT (1) ATE293459T1 (https=)
AU (1) AU1165899A (https=)
DE (1) DE69829880T2 (https=)
ES (1) ES2238774T3 (https=)
GB (1) GB9724143D0 (https=)
WO (1) WO1999025383A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
WO1999064072A1 (de) * 1998-06-10 1999-12-16 Baxter Aktiengesellschaft Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
AU6389000A (en) * 1999-07-28 2001-02-19 Valentis, Inc. Sonoporation of tumors
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
JP5230610B2 (ja) 2006-05-05 2013-07-10 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 二価ｓｍａｃ模倣物およびその使用
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US20090170195A1 (en) * 2007-12-28 2009-07-02 Kent State University Curcumin-hyaluronan compounds
CN102112144A (zh) 2008-05-16 2011-06-29 拜耳医药保健有限公司 靶向性凝固因子及其使用方法
JP5770161B2 (ja) * 2009-04-06 2015-08-26 ノヴォ ノルディスク アー／エス 血小板への第ｖｉｉｉ因子タンパク質の標的送達
GB201101740D0 (en) * 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970300A (en) * 1985-02-01 1990-11-13 New York University Modified factor VIII
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
WO1996039128A1 (en) 1995-06-06 1996-12-12 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
PT796090E (pt) * 1994-12-16 2003-07-31 Elan Drug Delivery Ltd Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos
ES2232862T3 (es) * 1996-10-21 2005-06-01 Quadrant Drug Delivery Limited Sustitutos de plaquetas y procedimientos de conjugacion apropiados para su preparacion.

Also Published As

Publication number Publication date
AU1165899A (en) 1999-06-07
JP2001523648A (ja) 2001-11-27
US7001989B2 (en) 2006-02-21
DE69829880T2 (de) 2005-09-22
ES2238774T3 (es) 2005-09-01
WO1999025383A1 (en) 1999-05-27
EP1047452B1 (en) 2005-04-20
EP1047452A1 (en) 2000-11-02
DE69829880D1 (de) 2005-05-25
US20030087826A1 (en) 2003-05-08
ATE293459T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
GB9724143D0 (en) Pharmaceutical conjugate
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
PT1176961E (pt) Sistemas de administracao de nicotina
AU5956398A (en) Remedies for lymphocytic tumors
CA2166931A1 (en) Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
CA2309818A1 (en) Buffered drug formulations for transdermal electrotransport delivery
GB2331208A9 (en) Restoring failed telecoms links using software agents
NO20002800L (no) Cyklosporinholdig mikroemulsjon, for konsentratsammensetning
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
TR199902199T2 (xx) Siklosporin tatbiki i�in hidrofilik ikili sistemler.
ID26163A (id) Sistem penggasan bahan bakar
GB9711115D0 (en) Integrin-targeting vectors having enhanced transfection activity
SG168401A1 (en) Catalyst and use thereof
BR9808770A (pt) Conjugado medicamentoso, método para suaprodução e seu uso
UA32522C2 (uk) Ліофілізована протипухлинна композиція і стерильна водна композиція для ін'єкцій на її основі
WO1997023240A3 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
ID28459A (id) Katalisator radial, khusus untuk mesin kecil
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
EP0607897A3 (en) Hydraulically-damped, active engine support.
DK0815141T3 (da) Antistof mod et fusionspolypeptid omfattende en histidinandel
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)